SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Politics : PRESIDENT GEORGE W. BUSH -- Ignore unavailable to you. Want to Upgrade?

To: Raymond Duray who wrote (495106)11/18/2003 7:36:34 PM
From: Dr. Voodoo  Read Replies (1) | Respond to of 769670
 
There are many substantiated cases were the basic science of a new drug is done at public expense through NIH and the IP is transferred to big Pharma which has little development cost involved, yet charges the public exorbitant prices,

OK genius, since you said it. It's time to put up or shut up. Name exactly TWO, and outline the development costs, and show how the pharmaceutical company is getting rich with "little development costs" compared to the NIH funding. No more making it up. Provide the links that prove it. Show how the public paid for the clinical trials.

I'll give you 24 hours.

Voodoo



To: Raymond Duray who wrote (495106)11/19/2003 7:39:34 PM
From: Dr. Voodoo  Read Replies (1) | Respond to of 769670
 
Well Ray,

Times up.

Where are those MANY substantiated cases?

There are many substantiated cases were the basic science of a new drug is done at public expense through NIH and the IP is transferred to big Pharma which has little development cost involved,

Voodoo


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News